Education
About Us
Working with TipRanks
Follow Us
Avanos Medical (AVNS)
NYSE:AVNS
Total Valuation
Avanos Medical has a market cap or net worth of $570.90M. The enterprise value is $794.82M.
Market Cap$570.90M
Enterprise Value$794.82M
Share Statistics
Avanos Medical has 46.00M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding46.00M
Owned by Insiders2.31%
Owned by Instutions0.05%
Financial Efficiency
Avanos Medical’s return on equity (ROE) is -0.47 and return on invested capital (ROIC) is -37.63%.
Return on Equity (ROE)-47.33%
Return on Assets (ROA)-33.97%
Return on Invested Capital (ROIC)-37.63%
Return on Capital Employed (ROCE)-40.09%
Revenue Per Employee$308,845.981
Profits Per Employee-$176,066.457
Employee Count2,227
Asset Turnover0.60
Inventory Turnover2.21
Valuation Ratios
The current PE Ratio of Avanos Medical is -1.87. Avanos Medical’s PEG ratio is >-0.01.
PE Ratio-1.87
PS Ratio1.06
PB Ratio0.88
Price to Fair Value0.88
Price to FCF8.83
Price to Operating Cash Flow7.27
PEG Ratio>-0.01
Income Statement
In the last 12 months, Avanos Medical had revenue of $687.80M and earned -$392.10M in profits. Earnings per share was -$8.53.
Revenue$687.80M
Gross Profit$381.30M
Operating Income-$383.00M
Pretax Income-$403.30M
Net Income-$392.10M
EBITDA-340.30M
Earnings Per Share (EPS)-8.53
Cash Flow
In the last 12 months, operating cash flow was $100.70M and capital expenditures -$17.80M, giving a free cash flow of $82.90M billion.
Operating Cash Flow$100.70M
Free Cash Flow$82.90M
Free Cash Flow per Share$1.80
Dividends & Yields
Avanos Medical pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield11.32%
Earnings Yield-53.54%
Stock Price Statistics
Beta0.96
52-Week Price Change-33.46%
50-Day Moving Average14.94
200-Day Moving Average19.19
Relative Strength Index (RSI)30.62
Average Volume (3m)525.18K
Important Dates
Avanos Medical upcoming earnings date is Apr 30, 2025, Before Open.
Last Earnings DateFeb 26, 2025
Next Earnings DateApr 30, 2025
Ex-Dividend Date―
Financial Position
Avanos Medical as a current ratio of 2.37, with Debt / Equity ratio of 0.21
Current Ratio2.37
Quick Ratio1.53
Debt to Market Cap0.23
Net Debt to EBITDA-0.18
Interest Coverage Ratio-32.48
Taxes
In the past 12 months, Avanos Medical has paid -$17.00M in taxes.
Income Tax-$17.00M
Effective Tax Rate4.22%
Enterprise Valuation
Avanos Medical EV to EBITDA ratio is -2.30, with an EV/FCF ratio of 9.59.
EV to Sales1.16
EV to EBITDA-2.30
EV to Free Cash Flow9.59
EV to Operating Cash Flow7.89
Balance Sheet
Avanos Medical has $107.70M in cash and marketable securities with $170.20M in debt, giving a net cash position of $62.50M billion.
Cash & Marketable Securities$107.70M
Total Debt$170.20M
Net Cash$62.50M
Net Cash Per Share$1.36
Tangible Book Value Per Share$5.67
Margins
Gross margin is 55.44%, with operating margin of -57.60%, and net profit margin of -57.01%.
Gross Margin55.44%
Operating Margin-57.60%
Pretax Margin-58.64%
Net Profit Margin-57.01%
EBITDA Margin-50.25%
EBIT Margin-56.86%
Analyst Forecast
The average price target for Avanos Medical is $17.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$17.00
Price Target Upside36.99%
Analyst ConsensusHold
Analyst Count2
Revenue Growth Forecast-2.54%
EPS Growth Forecast-546.91%